metricas
covid
Neurology perspectives
Journal Information
Issue
portada-S2667049625X0003XVol. 5. Issue 3.
(July - September 2025)
Original articles
Retrospective, multi-centre, open-label study on the use of alemtuzumab for relapsing–remitting multiple sclerosis in clinical practice: A 4-year follow-up
A. Pato-Pato, P. Gabeiras-Araujo, M. Lorenzo-García, C. Hernandez-Cerón, J.R. Lorenzo-González, D.A. García-Estévez
Full text access
Review
Autoimmune skin diseases in multiple sclerosis
M. Roncero Riesco, A. Cabanillas Cabral, Y. El Berdei Montero
Full text access
Autoimmune eye diseases in multiple sclerosis
M.L. Martínez Ginés, P. Rojas Lozano
Full text access
Inflammatory bowel disease and multiple sclerosis
M. Dominguez-Gallego, V. Meca-Lallana, A.B. Caminero
Full text access
Other autoimmune diseases and multiple sclerosis
S. Martínez-Yélamos, Á. Pérez-Sempere
Full text access
Editor letter
Myasthenic crisis probably triggered by local lidocaine infiltration unveiling generalized myasthenia gravis without extraocular muscle involvement
M. León-Ruiz, C. Rízea, J. Álvarez-Troncoso, M. Quintana-Díaz, G. Zmork-Martínez, J. Benito-León, J. Rodríguez-Pardo
Full text access